accountwill enroll over 500 patients. Synteract, dedicated to meeting the clinical research needs of biotechnology, medical device and pharmaceutical companies worldwide, has greater than 90 percent repeat and referral rate due to its expertise, integrity and...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Synteract and Mpex Pharmaceuticals Team Up for Cystic Fibrosis Walk and Cure
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account